Clinical Trials Browser

Interventional × Recurrence × Immunotherapy × Clear all

NCT04981665 2022-01-05

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Phase NA Unknown

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence